EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP‐C founder mutation

Najlaa Khalat, Olfa Messaoud iD, Mariem Ben Rekaya, Mariem Chargui, Mohamed Zghal, Bashir Zendah, Najat Saqer, Mourad Mokni, Sonia Abdelhak, Othman A Mohamed

Molecular Genetics & Genomic Medicine · 2023-06 · 11 (6)

DOI: 10.1002/mgg3.2158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 22.02.2023. Verfasst von Najlaa Khalat und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Libyan Academy, Tripoli, Libya. Hauptthemen laut MEDLINE: Xeroderma Pigmentosum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xeroderma pigmentosum is an autosomal recessive disease characterized by a high sensitivity to UV radiations. The disease is clinically and genetically heterogeneous, thus making accurate early clinical diagnosis difficult. Although the disease is considered rare worldwide, previous studies have shown that it is more frequent in Maghreb countries. So far, no genetic study has been published on Libyan patients, except three reports limited to clinical descriptions.

Methods

Our study, which represents the first genetic characterization of XP in Libya, was conducted on 14 unrelated families including 23 Libyan XP patients with a consanguinity rate of 93%. Blood samples were collected from 201 individuals including patients and their relatives. Patients were screened for founder mutations already described in Tunisia.

Results

The two founder Maghreb XP mutations, XPA p.Arg228* associated with the neurological form and XPC p.Val548Alafs*25 in patients with only cutaneous manifestations, were homozygously identified. The latter was predominant (19 of 23 patients). In addition, another XPC homozygous mutation (p.Arg220*) has been identified in only one patient. For the remaining patient, the absence of founder XPA , XPC , XPD, and XPG mutations suggests mutational heterogeneity of XP in Libya.

Conclusion

Identification of common mutations with other Maghreb populations is in favor of a common ancestor in North‐African populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xeroderma PigmentosumHumansDNA-Binding ProteinsLibyaMutationTunisia

Stichwörter der Autor:innen

Xeroderma pigmentosumLibyaMaghreb mutationsfounder effectmutational heterogeneity

Substanzen

DNA-Binding Proteins

Autor:innen und Institutionen

  • The Libyan Academy, Tripoli, Libya.
  • Institut Pasteur de Tunis, Biomedical Genomics and Oncogenetics Laboratory, University Tunis El Manar, Tunis, Tunisia.
  • Dermatology Department, Charles Nicolle Hospital, Tunis, Tunisia.
  • Dermatology Department, Medical Tripoli Centre (MTC), Tripoli, Libya.
  • Dermatology Department, Central Tripoli Hospital, Tripoli, Libya.
  • Dermatology Department, La Rabta Hospital, Tunis, Tunisia.

ORCID-Profile: Olfa Messaoud

Zitieren

APA

Khalat, N., Messaoud, O., Ben Rekaya, M., Chargui, M., Zghal, M., Zendah, B., Saqer, N., Mokni, M., Abdelhak, S., & Mohamed, O. A. (2023). First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP‐C founder mutation. Molecular Genetics & Genomic Medicine, 11(6). https://doi.org/10.1002/mgg3.2158

Vancouver

Khalat N, Messaoud O, Ben Rekaya M, Chargui M, Zghal M, Zendah B, et al. First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP‐C founder mutation. Molecular Genetics & Genomic Medicine. 2023;11(6). doi:10.1002/mgg3.2158

BibTeX
@article{Khalat2023,
  author = {Khalat, Najlaa and Messaoud, Olfa and Ben Rekaya, Mariem and Chargui, Mariem and Zghal, Mohamed and Zendah, Bashir and Saqer, Najat and Mokni, Mourad and Abdelhak, Sonia and Mohamed, Othman A},
  title = {First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP‐C founder mutation},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  volume = {11},
  number = {6},
  doi = {10.1002/mgg3.2158}
}
Kostenlos starten →